Form 8-A12B - Registration of securities [Section 12(b)]
2024年2月13日 - 5:04AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-A
FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES
PURSUANT TO SECTION 12(b) OR (g) OF
THE SECURITIES EXCHANGE ACT OF 1934
REVIV3 PROCARE COMPANY*
(Exact name of registrant as specified in its charter)
Delaware
(State of Incorporation or Organization) |
47-4125218
(I.R.S. Employer Identification No.) |
|
|
901 Fremont Avenue, Unit 158, Alhambra, CA
(Address of Principal Executive Offices) |
91803
(Zip Code) |
Securities to be registered pursuant to Section 12(b) of the Act:
Title of each class to be so registered |
|
Name of each exchange on which each class is to be registered |
Shares of Common Stock, par value $0.0001 per share |
|
The NYSE American LLC |
If this form relates to the registration of a
class of securities pursuant to Section 12(b) of the Exchange Act and is effective pursuant to General Instruction A.(c) or (e), check
the following box. [X]
If this form relates to the registration of a
class of securities pursuant to Section 12(g) of the Exchange Act and is effective pursuant to General Instruction A.(d) or (e), check
the following box. [ ]
If this form relates to the registration of a
class of securities concurrently with a Regulation A offering, check
the following box. [ ]
Securities Act registration statement or Regulation A offering statement
file number to which this form relates: (if applicable)
Securities to be registered pursuant to Section
12(g) of the Act: None.
* The Registrant is currently named Reviv3 Procare
Company. Prior to the consummation of the Listing (as defined in this Form 8-A), the Registrant plans to change its name to “AXIL
Brands, Inc.”
EXPLANATORY NOTE
This Registration
Statement on Form 8-A is being filed by Reviv3 Procare Company, a Delaware corporation (the
“Company”), with the U.S. Securities and Exchange Commission (the “SEC”) in connection with the listing of the Company’s
common stock, par value $0.0001 per share (the “Common Stock”) on the NYSE American LLC (the “Listing”). The Company
plans to change its name from “Reviv3 Procare Company” to “AXIL Brands,
Inc.” prior to the consummation of the Listing. The Common Stock will trade on the NYSE American
under the trading symbol “AXIL.”
INFORMATION REQUIRED IN REGISTRATION STATEMENT
Item 1. Description of Registrant’s Securities
to be Registered.
For a description
of the securities registered hereunder, the Common Stock of the Company, reference is made
to the information set forth under the heading “Description of Reviv3 Procare Company Common Stock” in Exhibit
4.1 to the Company’s Annual Report on Form 10-K for the year ended May 31, 2022, filed with the SEC on August 25, 2022,
which information is incorporated herein by reference.
Item 2. Exhibits.
Pursuant
to the Instructions as to Exhibits for Form 8-A, no exhibits are required to be filed, because no other securities of the Company are
registered on the NYSE American LLC, and the securities registered hereby are not being registered pursuant to Section 12(g) of the Securities
Exchange Act of 1934, as amended.
SIGNATURE
Pursuant to the requirements of Section 12 of
the Securities Exchange Act of 1934, the registrant has duly caused this registration statement to be signed on its behalf by the undersigned,
thereto duly authorized.
Date: February 12, 2024 |
REVIV3 PROCARE COMPANY |
|
|
|
|
By: |
/s/ Jeff Toghraie |
|
Name: |
Jeff Toghraie |
|
Title: |
Chief Executive Officer |
Reviv3 Procare (QB) (USOTC:RVIV)
過去 株価チャート
から 7 2024 まで 8 2024
Reviv3 Procare (QB) (USOTC:RVIV)
過去 株価チャート
から 8 2023 まで 8 2024